MAIA
Price
$1.70
Change
-$0.01 (-0.58%)
Updated
Jul 25 closing price
Capitalization
52.31M
9 days until earnings call
VRNA
Price
$105.30
Change
+$0.30 (+0.29%)
Updated
Jul 25 closing price
Capitalization
8.96B
4 days until earnings call
Interact to see
Advertisement

MAIA vs VRNA

Header iconMAIA vs VRNA Comparison
Open Charts MAIA vs VRNABanner chart's image
MAIA Biotechnology
Price$1.70
Change-$0.01 (-0.58%)
Volume$102.16K
Capitalization52.31M
Verona Pharma
Price$105.30
Change+$0.30 (+0.29%)
Volume$1.75M
Capitalization8.96B
MAIA vs VRNA Comparison Chart in %
Loading...
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MAIA vs. VRNA commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAIA is a Hold and VRNA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (MAIA: $1.70 vs. VRNA: $105.30)
Brand notoriety: MAIA and VRNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MAIA: 25% vs. VRNA: 42%
Market capitalization -- MAIA: $52.31M vs. VRNA: $8.96B
MAIA [@Biotechnology] is valued at $52.31M. VRNA’s [@Biotechnology] market capitalization is $8.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAIA’s FA Score shows that 0 FA rating(s) are green whileVRNA’s FA Score has 1 green FA rating(s).

  • MAIA’s FA Score: 0 green, 5 red.
  • VRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, VRNA is a better buy in the long-term than MAIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAIA’s TA Score shows that 2 TA indicator(s) are bullish while VRNA’s TA Score has 3 bullish TA indicator(s).

  • MAIA’s TA Score: 2 bullish, 7 bearish.
  • VRNA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VRNA is a better buy in the short-term than MAIA.

Price Growth

MAIA (@Biotechnology) experienced а +0.59% price change this week, while VRNA (@Biotechnology) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

MAIA is expected to report earnings on Aug 05, 2025.

VRNA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRNA($8.96B) has a higher market cap than MAIA($52.3M). VRNA YTD gains are higher at: 126.744 vs. MAIA (-14.141). MAIA has higher annual earnings (EBITDA): -24.75M vs. VRNA (-121.41M). VRNA has more cash in the bank: 401M vs. MAIA (10.9M). VRNA has higher revenues than MAIA: VRNA (119M) vs MAIA (0).
MAIAVRNAMAIA / VRNA
Capitalization52.3M8.96B1%
EBITDA-24.75M-121.41M20%
Gain YTD-14.141126.744-11%
P/E RatioN/AN/A-
Revenue0119M-
Total Cash10.9M401M3%
Total DebtN/A244M-
FUNDAMENTALS RATINGS
VRNA: Fundamental Ratings
VRNA
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
2
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MAIAVRNA
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 19 days ago
88%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 14 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
70%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GOVZ9.240.09
+0.98%
iShares 25+ Year Treasury STRIPS Bd ETF
TEK28.820.10
+0.34%
iShares Technology Opports Act ETF
WTBN25.350.03
+0.14%
WisdomTree Bianco Fixed Inc Ttl Ret ETF
IWTR33.52N/A
N/A
iShares MSCI Water Mgmt Mltsctr ETF
SCHY27.61-0.05
-0.18%
Schwab International Dividend Equity ETF

MAIA and

Correlation & Price change

A.I.dvisor tells us that MAIA and ARDX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAIA and ARDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
-0.58%
ARDX - MAIA
31%
Poorly correlated
-1.61%
IPSC - MAIA
29%
Poorly correlated
-5.17%
TERN - MAIA
28%
Poorly correlated
N/A
VRNA - MAIA
28%
Poorly correlated
+0.29%
RZLT - MAIA
27%
Poorly correlated
+7.33%
More

VRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNA has been loosely correlated with RYTM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VRNA jumps, then RYTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRNA
1D Price
Change %
VRNA100%
+0.29%
RYTM - VRNA
44%
Loosely correlated
-0.94%
IRON - VRNA
41%
Loosely correlated
-0.54%
ZYME - VRNA
41%
Loosely correlated
-4.85%
ARCT - VRNA
41%
Loosely correlated
-0.07%
CRNX - VRNA
41%
Loosely correlated
N/A
More